大葉大學圖書館 |

Breast cancer biology for the radiation oncologist[electronic resource] /

紀錄類型:	書目-電子資源 : Monograph/item
杜威分類號:	616.99449
書名/作者:	Breast cancer biology for the radiation oncologist/ edited by Jonathan Strauss, William Small, Gayle E. Woloschak.
其他作者:	Strauss, Jonathan.
出版者:	Berlin, Heidelberg : : Springer Berlin Heidelberg :, 2015.
面頁冊數:	vii, 90 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Breast - Cancer
標題:	Medicine & Public Health.
標題:	Radiotherapy.
標題:	Oncology.
ISBN:	9783642312205 (electronic bk.)
ISBN:	9783642312199 (paper)
內容註:	Biological subtypes of breast cancer -- Oncogene amplification and Herceptin -- Current clinical use of genetic profiling -- Biology of DCIS and progression to invasive disease -- Cancer Stem Cells and Radiotherapy -- Genetic basis of normal tissue radiosensitivity and late toxicity -- Genetic syndromes and radiotherapy in breast cancer -- Experimental therapies in breast cancer.
摘要、提要註:	Breast Cancer Biology for the Radiation Oncologist is the first textbook of its kind devoted to describing the biological complexities of breast cancer in a way that is relevant to the radiation oncologist. Radiation Oncology has long treated breast cancer as a single biological entity, with all treatment decisions being based on clinical and pathologic risk factors. We are now beginning to understand that biological subtypes of breast cancer may have different risks of recurrence as well as different intrinsic sensitivity to radiotherapy. Multi-gene arrays that have for years been used to predict the risk of distant recurrence and the value of systemic chemotherapy may also have utility in predicting the risk of local recurrence. Additionally, the targeted agents used to treat breast cancer may interact with radiotherapy in ways that can be beneficial or undesirable. All of these emerging issues of central importance to radiation oncologists are extensively discussed in this book, and practical treatment recommendations based on available clinical evidence are presented whenever possible.
電子資源:	http://dx.doi.org/10.1007/978-3-642-31220-5

Breast cancer biology for the radiation oncologist[electronic resource] /
Breast cancer biology for the radiation oncologist[electronic resource] /edited by Jonathan Strauss, William Small, Gayle E. Woloschak. - Berlin, Heidelberg :Springer Berlin Heidelberg :2015. - vii, 90 p. :ill., digital ;24 cm. - Medical radiology,0942-5373. - Medical radiology..

Biological subtypes of breast cancer -- Oncogene amplification and Herceptin -- Current clinical use of genetic profiling -- Biology of DCIS and progression to invasive disease -- Cancer Stem Cells and Radiotherapy -- Genetic basis of normal tissue radiosensitivity and late toxicity -- Genetic syndromes and radiotherapy in breast cancer -- Experimental therapies in breast cancer.

Breast Cancer Biology for the Radiation Oncologist is the first textbook of its kind devoted to describing the biological complexities of breast cancer in a way that is relevant to the radiation oncologist. Radiation Oncology has long treated breast cancer as a single biological entity, with all treatment decisions being based on clinical and pathologic risk factors. We are now beginning to understand that biological subtypes of breast cancer may have different risks of recurrence as well as different intrinsic sensitivity to radiotherapy. Multi-gene arrays that have for years been used to predict the risk of distant recurrence and the value of systemic chemotherapy may also have utility in predicting the risk of local recurrence. Additionally, the targeted agents used to treat breast cancer may interact with radiotherapy in ways that can be beneficial or undesirable. All of these emerging issues of central importance to radiation oncologists are extensively discussed in this book, and practical treatment recommendations based on available clinical evidence are presented whenever possible.

ISBN: 9783642312205 (electronic bk.)

Standard No.: 10.1007/978-3-642-31220-5doiSubjects--Topical Terms:

387698
Breast
--Cancer

LC Class. No.: RC280.B8

Dewey Class. No.: 616.99449

Breast cancer biology for the radiation oncologist[electronic resource] /
LDR:02508nmm a2200325 a 4500 001 439040
003 DE-He213
005 20160108101423.0
006 m d
007 cr nn 008maaau
008 160315s2015 gw s 0 eng d
020 $a 9783642312205 (electronic bk.)
020 $a 9783642312199 (paper)
024 7 $a 10.1007/978-3-642-31220-5 $2 doi
035 $a 978-3-642-31220-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B8
072 7 $a MJCL1 $2 bicssc
072 7 $a MED080000 $2 bisacsh
082 0 4 $a 616.99449 $2 23
090 $a RC280.B8 $b B828 2015
245 0 0 $a Breast cancer biology for the radiation oncologist $h [electronic resource] / $c edited by Jonathan Strauss, William Small, Gayle E. Woloschak.
260 $a Berlin, Heidelberg : $b Springer Berlin Heidelberg : $b Imprint: Springer, $c 2015.
300 $a vii, 90 p. : $b ill., digital ; $c 24 cm.
490 1 $a Medical radiology, $x 0942-5373
505 0 $a Biological subtypes of breast cancer -- Oncogene amplification and Herceptin -- Current clinical use of genetic profiling -- Biology of DCIS and progression to invasive disease -- Cancer Stem Cells and Radiotherapy -- Genetic basis of normal tissue radiosensitivity and late toxicity -- Genetic syndromes and radiotherapy in breast cancer -- Experimental therapies in breast cancer.
520 $a Breast Cancer Biology for the Radiation Oncologist is the first textbook of its kind devoted to describing the biological complexities of breast cancer in a way that is relevant to the radiation oncologist. Radiation Oncology has long treated breast cancer as a single biological entity, with all treatment decisions being based on clinical and pathologic risk factors. We are now beginning to understand that biological subtypes of breast cancer may have different risks of recurrence as well as different intrinsic sensitivity to radiotherapy. Multi-gene arrays that have for years been used to predict the risk of distant recurrence and the value of systemic chemotherapy may also have utility in predicting the risk of local recurrence. Additionally, the targeted agents used to treat breast cancer may interact with radiotherapy in ways that can be beneficial or undesirable. All of these emerging issues of central importance to radiation oncologists are extensively discussed in this book, and practical treatment recommendations based on available clinical evidence are presented whenever possible.
650 0 $a Breast $x Cancer $x Treatment. $3 387698
650 1 4 $a Medicine & Public Health. $3 463493
650 2 4 $a Radiotherapy. $3 403282
650 2 4 $a Oncology. $3 205017
700 1 $a Strauss, Jonathan. $3 626627
700 1 $a Small, William. $3 343345
700 1 $a Woloschak, Gayle E. $3 626628
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Medical radiology. $3 464156
856 4 0 $u http://dx.doi.org/10.1007/978-3-642-31220-5
950 $a Medicine (Springer-11650)